UC WAR. CALL 12/24 4AB/ DE000HC61XN3 /
05/09/2024 08:02:26 | Chg.-0.1300 | Bid09:23:36 | Ask09:23:36 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
3.4400EUR | -3.64% | 3.4600 Bid Size: 3,000 |
3.6000 Ask Size: 3,000 |
ABBVIE INC. D... | 160.00 - | 18/12/2024 | Call |
GlobeNewswire
29/08
Great Place To Work Announces the 2024 Best Workplaces in Asia Representing 6.9 Million Employee Exp...
GlobeNewswire
28/08
Royalty Pharma to Present at Morgan Stanley’s 22nd Annual Global Healthcare Conference
GlobeNewswire
28/08
Nxera Pharma Notes Positive Phase 2 Data for Partnered Schizophrenia Candidate NBI-1117568
GlobeNewswire
23/08
NurExone Biologic Invited to Present Groundbreaking ExoPTEN Therapy at Prestigious September Confere...
GlobeNewswire
19/08
TEPKINLY® (epcoritamab) Receives Second European Commission Approval for the Treatment of Adults wit...
GlobeNewswire
15/08
Alvotech Reports Record Revenues and Adjusted EBITDA for the Second Quarter and First Six Months of ...
GlobeNewswire
09/08
Nxera Pharma Operational Highlights and Consolidated Results for the Second Quarter and First Half 2...
GlobeNewswire
08/08
CytomX Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
07/08
Alector Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
06/08
Caribou Biosciences Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
01/08
Outpace Bio Announces $144M Oversubscribed Series B Financing to Advance AI-powered Cell Therapies i...
GlobeNewswire
01/08
CytomX Therapeutics to Report Second Quarter 2024 Financial Results on August 8, 2024
GlobeNewswire
01/08
NodThera Announces Appointment of Greg Chow as Chief Financial and Business Officer
GlobeNewswire
31/07
Fate Therapeutics Appoints Neely Mozaffarian, MD, PhD, FACR, to its Board of Directors
GlobeNewswire
31/07
Umoja Biopharma Announces FDA Clearance of IND Application for UB-VV111, a CD19 Directed in situ CAR...
GlobeNewswire
30/07
Montara Therapeutics Closes $8 Million Seed Round Led by SV Health Investors’ Dementia Discovery Fun...